Healthcare & Life Sciences

The MEMS specialist saw revenue dip on a sharp medical decline, but booming aerospace sales, a higher margin, and a new dividend signal a strategic pivot.

CompHealth's Joint Commission certification signals a deep commitment to quality, but what does this 'Gold Seal' truly mean for hospitals and patient safety?

As AI reshapes the $10 trillion wellness industry, one franchise doubles down on an old-school approach: human empathy. But can it truly compete?

With 1.9M players and only 1 public court per 6,700 residents, USTA Florida calls for urgent investment to meet surging demand and unlock economic benefits.

The handyman franchise's recent honor from Entrepreneur reveals a surge in demand, driven by an aging population and the power of a robust franchise system.

The 72nd Greater San Diego Science and Engineering Fair awarded $40k, showcasing student innovations in AI, medicine, and environmental science.

John Snow Labs earns a key AWS competency, signaling a shift toward secure, domain-specific AI to tackle healthcare's toughest regulatory and data challenges.

A new report reveals 76% of healthcare organizations are unprepared for AI, despite leaders viewing it as critical, fueling a worsening staffing crisis.

In a strategic play, VIVUS is slashing the price of its oral obesity drug QSIVA, challenging the dominance of costly new injectables like Wegovy.

A landmark settlement by Jushi Holdings sets a new precedent in the fight against unregulated hemp products, highlighting deep industry rifts and public safety risks.

ATI Physical Therapy returns to the McDonald's All American Games, providing elite medical care and championing local adaptive sports through a key grant.

In its first-ever Match Day, the Kansas College of Osteopathic Medicine surpassed national averages, placing new doctors in critical primary care roles.

Swisslog launches AgileStore, a 4-way roaming pallet shuttle designed to maximize density and adapt to any warehouse, even in deep-freeze conditions.

With €10M in new funding, Berlin-based Cellbricks is moving its biofabricated human tissues from lab to preclinical trials, promising a new era for patients.

Maze Therapeutics posts positive Phase 2 data for its genetic kidney disease drug, but a sharp stock drop reveals investor concerns in a competitive race.

As cyberattacks increasingly target user identities, ID Dataweb's award-winning platform highlights a new defense that verifies trust without friction.

The architect of Canada's Olympic hockey dynasty, Melody Davidson, will take the reins of the CSSHL, bringing her legendary expertise to the growing league.

GSD seeks dual US-based accreditations, a strategic move to bolster its global standing and elevate student value in a competitive academic landscape.

As AI agents drive up costs and create a 'token shortage,' a new player unveils a distributed compute network to challenge the centralized cloud model.

With two renowned physician leaders, Pediatrix signals a major push into AI-driven innovation and health equity for maternal and child medicine.